Novo integrated sciences reports fiscal year 2023 third quarter financial results

Bellevue, wash.--(business wire)---- $nvos #aapi--novo integrated sciences, inc. (nasdaq:nvos) (the “company” or “novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the third fiscal quarter ended may 31, 2023. robert mattacchione, novo's ceo and board chairman, stated, “the company remains committed to the commercial.
NVOS Ratings Summary
NVOS Quant Ranking